Form 4: Arlo CEO McRae Gifts Shares, Sells Stock Via 10b5-1 Plan

Sentiment:

Insider Transaction Report


Arlo Technologies CEO Matthew Blake McRae reported a charitable gift of 563,293 shares and the sale of 257,242 shares under a pre-arranged 10b5-1 trading plan.

Summary

  • Matthew Blake McRae, CEO and Director of Arlo Technologies, Inc. (ARLO), reported two transactions involving common stock.
  • On November 28, 2025, McRae made a charitable gift of 563,293 shares of common stock to a donor advised fund. The transaction price was $0.
  • Following this gift, McRae beneficially owned 1,198,828 shares.
  • On December 1, 2025, McRae sold 257,242 shares of common stock.
  • The sales were executed at a weighted average price of $14.2779 per share, with prices ranging from $14.06 to $14.42.
  • These sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by McRae on March 14, 2025.
  • After these transactions, McRae beneficially owns 941,586 shares of Arlo Technologies common stock.

Sentiment

Score: 6

Explanation: The filing reports a pre-planned insider stock sale and a charitable gift. While a sale reduces insider ownership, its execution under a 10b5-1 plan mitigates negative sentiment, suggesting a structured financial management decision rather than a reaction to adverse company news. The charitable gift adds a positive note.

Positives

  • The charitable gift of 563,293 shares demonstrates philanthropic activity by the CEO.
  • The stock sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and pre-scheduled divestment rather than an immediate reaction to market conditions.

Negatives

  • The sale of 257,242 shares by the CEO represents a reduction in direct insider ownership, which some investors might view as a slight negative, although it was pre-planned.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: The sale of shares by the CEO could be interpreted differently by shareholders; some may see it as a normal part of executive compensation and financial planning (especially given the 10b5-1 plan), while others might view it as a reduction in insider confidence, though the latter is less likely with a pre-planned sale. The charitable gift has no direct financial impact on other stakeholders.

Next Steps

  • Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the Issuer, or any security holder of the Issuer.

Key Dates

DateDescription
2025-03-14Date Rule 10b5-1 trading plan was adopted by Matthew Blake McRae.
2025-11-28Date of charitable gift of 563,293 shares of common stock.
2025-12-01Date of sale of 257,242 shares of common stock under 10b5-1 plan.
2025-12-01Date Form 4 was signed by Brian Busse, Attorney-in-Fact.

Recommendation

hold

The filing details a pre-scheduled insider stock sale and a charitable gift by the CEO. The sale under a 10b5-1 plan indicates a planned divestment, not a reaction to new information, thus it doesn't inherently signal a change in the company's fundamental outlook. The charitable gift is a personal philanthropic act. These transactions are largely neutral in terms of immediate investment implications for the broader market, suggesting a 'hold' recommendation as they do not provide new fundamental data to alter an existing investment thesis.

Keywords

Arlo Technologies, ARLO, Matthew Blake McRae, Insider Trading, Form 4, Stock Sale, Charitable Gift, 10b5-1 Plan, CEO, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.